{
    "organizations": [],
    "uuid": "544f956e031fe2bfbc6d71f1df38e9158944efd9",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-evelo-biosciences-sees-ipo-of-531/brief-evelo-biosciences-sees-ipo-of-5-31-mln-shares-of-its-common-stock-priced-to-be-between-15-17-share-idUSFWN1S70MY",
    "ord_in_thread": 0,
    "title": "BRIEF-Evelo Biosciences Sees IPO Of 5.31 Mln Shares Of Its Common Stock Priced To Be Between $15-$17/ Share",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 30 (Reuters) - Evelo Biosciences Inc:\n* EVELO BIOSCIENCES INC SEES IPO OF 5.31 MILLION SHARES OF ITS COMMON STOCK PRICED TO BE BETWEEN $15.00 AND $17.00 PER SHARE - SEC FILING\n* EVELO BIOSCIENCES INC - INTENDS TO USE ABOUT $45-$50 MILLION OF IPO PROCEEDS TO FUND PROOF OF CONCEPT CLINICAL TRIALS IN INFLAMMATORY DISEASES PROGRAMS\n* EVELO BIOSCIENCES INC - INTENDS TO USE ABOUT $25-$35 MILLION OF IPO PROCEEDS TO FUND PROOF OF CONCEPT CLINICAL TRIALS IN ONCOLOGY PROGRAMS\n* EVELO BIOSCIENCES -INTENDS TO USE ABOUT $35-$45 MILLION OF IPO PROCEEDS TO INVEST IN PLATFORM AND TO ADVANCE ADDITIONAL PRECLINICAL DEVELOPMENT ACTIVITIES Source text ( bit.ly/2rbI2ON )\n ",
    "published": "2018-04-30T19:06:00.000+03:00",
    "crawled": "2018-05-01T20:13:03.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "evelo",
        "bioscience",
        "inc",
        "evelo",
        "bioscience",
        "inc",
        "see",
        "ipo",
        "million",
        "share",
        "common",
        "stock",
        "priced",
        "per",
        "share",
        "sec",
        "filing",
        "evelo",
        "bioscience",
        "inc",
        "intends",
        "use",
        "million",
        "ipo",
        "proceeds",
        "fund",
        "proof",
        "concept",
        "clinical",
        "trial",
        "inflammatory",
        "disease",
        "program",
        "evelo",
        "bioscience",
        "inc",
        "intends",
        "use",
        "million",
        "ipo",
        "proceeds",
        "fund",
        "proof",
        "concept",
        "clinical",
        "trial",
        "oncology",
        "program",
        "evelo",
        "bioscience",
        "use",
        "million",
        "ipo",
        "proceeds",
        "invest",
        "platform",
        "advance",
        "additional",
        "preclinical",
        "development",
        "activity",
        "source",
        "text"
    ]
}